---
schema_version: "secwatch.filing_event.v1"
accession: "0001816590-23-000072"
form_type: "8-K"
ticker: "CMPS"
cik: "0001816590"
company_name: "COMPASS Pathways plc"
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:45:55.059319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# COMPASS Pathways co-founder Ekaterina Malievskaia steps down as Chief Innovation Officer, remains on board

## Summary
- Dr. Malievskaia will step down as Chief Innovation Officer effective June 16, 2023, by mutual agreement.
- She will remain a non-executive director, Class I, with term expiring at 2024 annual meeting.
- Executive responsibilities will be assumed by the existing executive team.
- She co-founded COMPASS in 2017 and led the phase 2b trial of COMP360 psilocybin for treatment-resistant depression.
- Transitioning to non-executive director, she will receive annual cash retainer of $40,000 and equity awards.

## SEC filing metadata
- accession: 0001816590-23-000072
- form_type: 8-K
- ticker: CMPS
- cik: 0001816590
- company_name: COMPASS Pathways plc
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816590/000181659023000072/0001816590-23-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816590/000181659023000072/cmps-20230530.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001816590-23-000072
- JSON: https://secwatch.observer/filing/0001816590-23-000072.json
- Plain text: https://secwatch.observer/filing/0001816590-23-000072.txt

## Key facts
- Executive change
  Dr. Ekaterina Malievskaia changed role as Chief Innovation Officer at COMPASS Pathways plc.
  - Action: stepped down
  - Role: Chief Innovation Officer
  source text: Dr. Malievskaia will step down from her executive role and that her employment agreement will terminate effective June 16, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816590/000181659023000072/0001816590-23-000072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.